Analysis of correlation between protein expression of XRCC1 and ERCC1 with efficacy of concurrent radiochemotherapy and the prognosis of patients with esophageal aquamous cell carcinoma
Yaowen Zhang,Fuyou Zhou,Ruiping Xu,Ming Li,Zhiyong Zheng,Runchuan Ren,Ronggang Sun,Anping Zheng
DOI: https://doi.org/10.3969/j.issn.1004-437X.2016.08.005
2016-01-01
Abstract:Objective To analyze the correlation between protein expression of X -ray repair cross complementing group 1 (XRCC1)and excision repair cross complementing 1 (ERCC1)with efficacy of concurrent radiochemotherapy(CRT)and the prognosis of patients with esophageal aquamous cell carcinoma(ESCC).Methods Immunohistochemical SP method was used to measure the protein expression of XRCC1 and ERCC in 98 ESCC tissue samples before CRT.The Kaplan -Meier method was used for survival analysis,and the log rank test was used for analyzing the survival difference between negative and positive sam-ples.The Cox model was used for multivariate prognostic analysis.Results XRCC1 and ERCC1 protein were mainly expressed in the nucleus in ESCC.There was no correlation between them (r =-0.024,P =0.811 ).The positive expression rate of XRCC1 protein in ESCC tissues and normal esophageal tissues were 57.1%(56 /98)and 13.3%(4 /30)respectively (χ2 =17.702,P =0.000).The positive expression rate of ERCC1 protein in ESCC tissues and normal esophageal tissues were 36.7%(36 /98)and 10%(3 /30)respectively(χ2 =7.749,P =0.006).The level of ERCC1 was not correlated with clinical pathologic characteristics (P >0.05).The positive expression rate of ERCC1 protein in negative lymphnode group was 44.9% (31 /69), higher than 17.2% (5 /29)in positive lymphnode group,and the difference was statistically significant (χ2 =8.183,P =0.004).The patients with positive XRCC1 expression and negative XRCC1 expression had similar short -term responses(χ2 =0.894,P =0.344)as well as similar survival rates(χ2 =0.266,P =0.606).The RR of ERCC1 negative expression group was 90.3%(56 /62),and the RR of ERCC1 positive expression group was 80.5%(29 /36),but there was no statistically significant difference (χ2 =1.888,P =0.169).The median overall survival periods of ERCC1 negative expression group was 39 months (95% CI:29.313 ~48.687 months),higher than 25 months (95% CI:18.559 ~31.441 months)in positive expression group, the difference was statistically significant (χ2 =10.174,P =0.001).In multivariate analysis,the expression of ERCC1 was closely correlated with overall survival and was the independent prognostic factor (P =0.010,95% CI:1.180 ~3.450).Conclusion ERCC1 expression was associated with the efficacy of CRT,and the patients with ERCC1 positive expression had poor prognosis.